Head LiceSymptoms, Doctors, Treatments, Advances & More
Learn About Head Lice
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Zobair Younossi practices practicing medicine in Falls Church, Virginia. Dr. Younossi is rated as an Elite provider by MediFind in the treatment of Head Lice. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Hepatitis C, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Heart Transplant.
Quentin Anstee practices practicing medicine in Newcastle Upon Tyne, United Kingdom. Mr. Anstee is rated as an Elite expert by MediFind in the treatment of Head Lice. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, Tissue Biopsy, and Liver Transplant.
Atsushi Nakajima practices practicing medicine in Yokohama, Japan. Mr. Nakajima is rated as an Elite expert by MediFind in the treatment of Head Lice. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Intestinal Pseudo-Obstruction, Nonalcoholic Steatohepatitis (NASH), Endoscopy, and Colonoscopy.
Summary: The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associated steatotic liver disease (MASLD). The study will enroll adults who have MASLD based on non-invasive tests (NITs), which indicate they are more likely to develop MALO. Participants will be randomly ...
Summary: The goal of this observational study is to assess non-invasive tools' efficacy in predicting portal hypertension-related complications in individuals with advanced chronic liver disease. The main question it aims to answer are: \- what are the cut-off values for non-invasive tests (NITs) (including LSM, SSM) that predict the presence and occurrence of hepatic decompensation in individuals with adv...